DEXCOM INC — Director's Dealing 2020

Nov 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-11-08

Reporting Person: Stern Sadie (EVP Chief Human Resources Off)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-08	Common Stock	A	7707	$0.001	Acquired	7707	Direct

Footnotes

F1: Represents a grant of restricted stock units that vests in four annual installments on November 08, 2021, November 8, 2022, November 8, 2023 and November 8, 2024. Share units represent a contingent right to receive one share of Dexcom, Inc. common stock.

F2: Included in this number are 7,707 unvested restricted stock units, 7,707 of which were granted on November 8, 2020 and shall vest through November 8, 2024.